Phaxiam Therapeutics
Presence
Phaxiam Therapeutics is one of the...
Phaxiam Therapeutics is a company listed under the stock ticker PHXM (FR).
Executives
View the org chart displaying its 17 main executives
Most searched biographies at Phaxiam Therapeutics
- Thibaut Du Fayet, Chief Executive Officer
- Hilde Windels, Director
- Gil Beyen, Vice Chairman of the Board
Create your alert
to follow the executive moves at Phaxiam Therapeutics.
Biotechnology
Phaxiam Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by Phaxiam Therapeutics
- Newsroom - Phaxiam
- Newsroom - Phaxiam
- Newsroom - Phaxiam
- Corporate Presentation – Erytech
- Communiqués de Presse – Erytech
- Press Releases – Erytech
- Press Releases – Erytech
- Monthly information related to total number of voting rights and shares composing the share capital - September 30, 2020 | ERYTECH PHARMA SA
- ERYTECH establishes a financing facility with the implementation of an at-the-market program on Nasdaq with Cowen | ERYTECH PHARMA SA
- ERYTECH Provides Business Update and Reports Financial Results for the First Half of 2020 | ERYTECH PHARMA SA
- View more press releases Close
Social media about Phaxiam Therapeutics
- Phaxiam Therapeutics on Wikipedia, Google News & Yahoo Finance
- Phaxiam Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Thibaut Du Fayet 
Call Phaxiam Therapeutics at +33 47...
